Losartan Cost in New Mexico 2026: Cash Price, Medicaid, Insurance, and Discount Options

At a glance
- Cash price (generic, NM retail) / ~$10/month in 2026
- Brand-name Cozaar list price / ~$80/month
- New Mexico Medicaid coverage / Not covered as of 2025-2026
- Compounded losartan via 503A pharmacy / Available in NM; may cost $0/month through telehealth programs
- Telehealth prescribing / Legal in New Mexico
- Typical dose / 25-100 mg once daily oral tablet
- FDA approval date / 1995 (hypertension); 2001 (diabetic nephropathy in type 2 diabetes)
- Savings card (Merck) / Available; check eligibility at time of fill
- GoodRx best price (NM) / As low as $4-$9 for a 30-day supply at select pharmacies
- Primary indications / Hypertension, heart failure, diabetic nephropathy
What Does Losartan Actually Cost in New Mexico in 2026?
Generic losartan potassium tablets cost approximately $10 per month at New Mexico retail pharmacies when paying cash in 2026, making it one of the more affordable antihypertensive agents available without insurance. Brand-name Cozaar carries a manufacturer list price of about $80 per month, but prescribers and pharmacists across New Mexico almost universally write and dispense the generic, so most patients never encounter that list price.
Losartan belongs to the angiotensin II receptor blocker (ARB) class. The FDA first approved it in 1995 for hypertension and later in 2001 for reducing the risk of stroke in hypertensive patients with left ventricular hypertrophy, and for slowing the progression of diabetic nephropathy in patients with type 2 diabetes [1]. The drug is dosed once daily in tablet form, with doses ranging from 25 mg to 100 mg depending on indication and tolerability.
The LIFE trial (N=9,193, Lancet 2002) showed losartan reduced the composite of cardiovascular death, stroke, and myocardial infarction by 13% compared with atenolol (P<0.001 for the primary endpoint), with a particularly strong 25% relative risk reduction in fatal and non-fatal stroke [2]. That level of evidence explains why losartan sits firmly on every major hypertension guideline as a first-line or second-line agent, and why access and affordability matter so much for long-term outcomes.
Specific cash prices at New Mexico pharmacies vary by city and chain. Albuquerque, Las Cruces, Santa Fe, and Rio Rancho all have Walmart, Costco, Walgreens, CVS, and independent pharmacy options. Walmart's $4 generic program often includes losartan 25 mg and 50 mg (30-day supply). Costco Pharmacy in Albuquerque has consistently been among the cheapest options statewide, sometimes pricing 90-day supplies at under $15 total.
The table below summarizes the cost tiers a New Mexico patient might move through, from highest to lowest out-of-pocket exposure.
New Mexico Losartan Cost Tiers (2026)
| Tier | Route | Approximate Monthly Cost | |------|-------|--------------------------| | 1 | Brand Cozaar, no insurance | ~$80 | | 2 | Generic, no discount | ~$10 | | 3 | Generic + GoodRx or RxSaver | $4-$9 | | 4 | Generic + Merck savings card | $0-$5 (eligibility required) | | 5 | Compounded via 503A telehealth | $0 (program-dependent) |
Does New Mexico Medicaid Cover Losartan?
New Mexico Medicaid (Centennial Care, administered by MCOs including Blue Cross Blue Shield of NM, Molina, and Western Sky Community Care) does not currently list losartan on its preferred drug list (PDL) as a covered ARB in the standard formulary tier. This is a notable gap, given that hypertension affects an estimated 33.5% of New Mexico adults according to the CDC Behavioral Risk Factor Surveillance System [3].
Patients enrolled in Centennial Care who need an ARB may find other agents such as valsartan or irbesartan covered, depending on their managed care organization's specific formulary. A prior authorization (PA) request for losartan may succeed if a prescriber documents a clinical reason losartan is preferred, such as a prior tolerability issue with a covered ARB, or if the patient's diabetic nephropathy protocol specifically calls for losartan based on trial evidence. The RENAAL trial (N=1,513) demonstrated that losartan 50-100 mg daily reduced the risk of doubling serum creatinine, end-stage renal disease, or death by 16% compared to placebo in patients with type 2 diabetes and nephropathy (P=0.02) [4]. That trial data can support a PA argument.
If Medicaid does not cover losartan, New Mexico patients have several fallback options outlined in the sections below.
Which Insurance Plans Cover Losartan in New Mexico?
Most commercial insurance plans operating in New Mexico cover generic losartan. The drug appears on Tier 1 (preferred generic) or Tier 2 (non-preferred generic) on the majority of employer-sponsored and marketplace plans. Copays at Tier 1 typically run $0-$10 for a 30-day supply; Tier 2 copays are usually $10-$25.
New Mexico's state employee health plan (NMPSIA and PERA-administered plans) generally covers generic losartan with standard generic copays. Presbyterian Health Plan, one of the largest commercial carriers in the state, has historically placed generic losartan on its Tier 1 formulary with a $0 copay for enrolled members.
Medicare Part D coverage varies by plan. Because losartan is a generic, most Part D plans cover it, but patients in the coverage gap ("donut hole") may still face higher cost-sharing. The Inflation Reduction Act of 2022 caps out-of-pocket drug costs for Medicare enrollees at $2,000 per year starting in 2025, which should reduce exposure even for patients on multiple medications [5].
The American Heart Association's 2023 hypertension guideline states directly: "ARBs are recommended as first-line therapy in patients with hypertension and chronic kidney disease or diabetes with albuminuria" [6]. That guideline language is useful use when appealing a formulary exclusion.
Is Compounded Losartan Legal in New Mexico?
Yes. Compounding losartan through a licensed 503A pharmacy is legal in New Mexico, provided the pharmacy holds a valid New Mexico Board of Pharmacy permit and operates in compliance with USP standards. A 503A pharmacy compounds patient-specific prescriptions; it does not produce losartan for general sale without a prescription, which would violate federal law [7].
503B outsourcing facilities, which produce larger sterile batches, are less relevant for oral losartan tablets. The 503A pathway is the standard route for compounded oral ARBs in New Mexico.
One practical reason compounding matters for losartan: some telehealth platforms include compounded generic medications as part of a bundled monthly membership fee, effectively reducing the patient's marginal cost to $0. New Mexico residents can access these services legally because New Mexico allows telehealth prescribing across state lines when the prescribing clinician holds a valid license to practice in New Mexico or operates under a valid interstate compact authorization.
The New Mexico Board of Pharmacy enforces the state's compounding rules under NMAC 16.19.7. Patients should confirm any compounding pharmacy they use appears on the board's license verification portal before filling a prescription.
Can You Get Losartan via Telehealth in New Mexico?
Telehealth prescribing of losartan is fully legal in New Mexico. State law permits synchronous audio-video visits, and New Mexico joined the Interstate Medical Licensure Compact (IMLC), meaning clinicians licensed in multiple IMLC states may see New Mexico patients remotely.
Losartan is a Schedule-free, non-controlled prescription medication. No DEA registration is required for the prescriber, and no state-specific controlled substance waiver is needed. A provider can evaluate a patient's blood pressure history, current medications, kidney function labs, and potassium levels via telehealth and write a losartan prescription that a New Mexico pharmacy fills or that a mail-order pharmacy ships to a New Mexico address.
HealthRX clinicians routinely prescribe losartan 50 mg or 100 mg once daily for hypertension management via telehealth. Patients typically need a recent basic metabolic panel (BMP) to check baseline creatinine and potassium before initiating therapy, because ARBs can raise serum potassium and, in patients with bilateral renal artery stenosis, may impair kidney function. These labs can be ordered through a telehealth visit and completed at any LabCorp or Quest Diagnostics location in New Mexico.
What Savings Programs Exist for Losartan in New Mexico?
Several distinct programs can cut losartan costs for New Mexico patients.
GoodRx and Similar Discount Cards
GoodRx, RxSaver, and NeedyMeds offer free discount cards accepted at most New Mexico retail pharmacies. GoodRx prices for generic losartan 50 mg (30 tablets) range from approximately $4 at Costco Albuquerque to $9 at some independent pharmacies. These cards are not insurance and cannot be combined with Medicaid or Medicare Part D, but they are usable with most commercial plans if the discounted price is lower than the insurance copay.
Merck Patient Assistance and Savings Programs
Merck manufactures brand-name Cozaar. For commercially insured patients, Merck's savings card may reduce the monthly copay to as low as $5. Eligibility requires that the patient not be enrolled in a federal or state government insurance program (Medicare, Medicaid, CHIP, TRICARE). Income limits may apply depending on the specific program year. Because generic losartan costs roughly $10 without any card, the Merck savings program is most relevant to patients whose insurance specifically covers only brand-name Cozaar.
New Mexico RxConnect and State Assistance
New Mexico does not operate a state-run pharmaceutical assistance program specifically for ARBs as of 2026. However, the New Mexico Human Services Department administers enrollment in the federal Extra Help (Low Income Subsidy) program for Medicare Part D, which can reduce losartan copays to $0-$4 for qualifying low-income Medicare enrollees [8].
Manufacturer Direct Programs
Merck's Patient Assistance Program (MAP) provides Cozaar at no cost to uninsured or underinsured patients who meet income thresholds (generally at or below 200% of the federal poverty level). New Mexico's median household income in 2023 was approximately $57,000 according to the U.S. Census Bureau, and a meaningful portion of the state's population falls below the 200% FPL threshold that qualifies for these programs.
How Do You Choose the Cheapest Option for Losartan in New Mexico?
The cheapest route depends on your insurance status and whether you have any complicating health factors. Here is a practical decision path.
If you have commercial insurance: check your plan's formulary first. If losartan is Tier 1, your copay is likely already near $0-$10. If it is Tier 2 or higher, run a GoodRx search and pay cash if the discount price beats your copay.
No insurance at all: go directly to Walmart ($4 program), Costco, or use GoodRx at Walgreens or CVS. A 90-day supply will typically cost $9-$20 total.
On Medicaid (Centennial Care): losartan is not covered on the standard PDL. Ask your prescriber to request a prior authorization, or ask about switching to a covered ARB if there is no clinical reason to prefer losartan specifically.
On Medicare Part D: most plans cover generic losartan. Use Medicare's Plan Finder tool at cms.gov to compare Part D plan formularies in your New Mexico zip code before open enrollment each fall.
Prefer telehealth and minimal monthly cost: a bundled telehealth membership that includes compounded losartan through a 503A pharmacy may reduce costs to $0 per month, while giving you access to lab ordering, clinician visits, and prescription renewals in one flat fee.
Losartan Dosing and Monitoring Reminders for New Mexico Patients
Losartan is typically started at 50 mg once daily for hypertension, with dose titration to 100 mg once daily if blood pressure remains above target after 4-6 weeks [1]. For diabetic nephropathy, the RENAAL trial used 50-100 mg daily and showed meaningful renoprotection [4]. For heart failure, the ELITE II trial (N=3,152) used 50 mg daily and compared losartan against captopril [9].
Patients should have a BMP checked 1-2 weeks after starting or up-titrating losartan to monitor potassium and creatinine. A serum potassium above 5.5 mEq/L or a creatinine rise exceeding 30% from baseline warrants dose reduction or discontinuation. Losartan is contraindicated in pregnancy; women of childbearing potential should use effective contraception while taking any ARB [1].
New Mexico's altitude (Albuquerque sits at 5,312 feet; Santa Fe at 7,199 feet) does not significantly affect losartan pharmacokinetics or dosing, though dehydration from heat and dry climate can potentiate hypotension in patients on ARBs plus diuretics. Staying well hydrated and monitoring blood pressure at home is advisable, especially in summer months.
Why Losartan Adherence Matters More Than Cost Alone
Uncontrolled hypertension costs far more than a $10 monthly pill. The CDC estimates that hypertension-related hospitalizations cost an average of $16,000 per admission [3]. A 2021 analysis in JAMA found that medication non-adherence accounts for roughly 10% of hospitalizations and costs the U.S. health system an estimated $100-$300 billion annually [10].
New Mexico has one of the higher rates of cardiovascular mortality among Western states. The state's 2022 age-adjusted heart disease death rate was 183.7 per 100,000, above the national average of 167.9 per 100,000 (CDC WONDER database). Keeping losartan affordable and accessible directly addresses that burden.
The JNC 8 panel members writing in JAMA 2014 stated: "In the general nonblack population, including those with diabetes, initial antihypertensive treatment should include a thiazide-type diuretic, calcium channel blocker, ACE inhibitor, or ARB" [11]. Losartan satisfies the ARB criterion in that recommendation and is the only ARB with a specific FDA indication for stroke risk reduction in hypertensive patients with left ventricular hypertrophy.
For patients with hypertension and proteinuria exceeding 300 mg/day, the 2024 KDIGO chronic kidney disease guidelines recommend an ARB or ACE inhibitor as first-line therapy, with losartan specifically cited as having level-A evidence for renoprotection in type 2 diabetic nephropathy [12].
Frequently asked questions
›How much does losartan cost in New Mexico?
›Does New Mexico Medicaid cover losartan?
›Is compounded losartan legal in New Mexico?
›Can I get losartan via telehealth in New Mexico?
›Which insurance plans cover losartan in New Mexico?
›What is the cheapest way to get losartan in New Mexico?
›Are there New Mexico losartan discount programs?
›How does the Merck savings card work in New Mexico?
References
- FDA. Cozaar (losartan potassium) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020386s056lbl.pdf
- Dahlof B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003. https://pubmed.ncbi.nlm.nih.gov/11937178/
- Centers for Disease Control and Prevention. High blood pressure facts. https://www.cdc.gov/bloodpressure/facts.htm
- Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy (RENAAL). N Engl J Med. 2001;345(12):861-869. https://pubmed.ncbi.nlm.nih.gov/11565518/
- Centers for Medicare and Medicaid Services. Medicare Part D changes under the Inflation Reduction Act. https://www.cms.gov/inflation-reduction-act
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
- FDA. Compounding and the FDA: questions and answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Social Security Administration. Extra Help with Medicare prescription drug plan costs. https://www.ssa.gov/medicare/part-d-extra-help
- Pitt B, Poole-Wilson PA, Segal R, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure (ELITE II). Lancet. 2000;355(9215):1582-1587. https://pubmed.ncbi.nlm.nih.gov/10821361/
- Cutler RL, Fernandez-Llimos F, Frommer M, et al. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8(1):e016982. https://pubmed.ncbi.nlm.nih.gov/29358417/
- James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults (JNC 8). JAMA. 2014;311(5):507-520. https://pubmed.ncbi.nlm.nih.gov/24352797/
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117-S314. https://pubmed.ncbi.nlm.nih.gov/38490803/